Hypomagnesemia and Diabetic Nephropathy

To find if there is a corrolatation between Microalbuminurea and diabetic retinopathy, in daibetic patients

Completed

Looking for future studies?

Key information

Conditions

Diabetic Nephropathies Diabetes Complications Diabetes Mellitus Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Urogenital Diseases Urologic Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of medicine Fayoum univesity

Al Fayyum, Egypt

About this study

40 Daibetic patients with microalbuminurea will be subjeted to full clinical examination and fundus examination,20 control diabetics with out microalbuminurea will also be included for comparison,patients will be selected from the outpatient clinic 0f fayoum university hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diabetics on oral treatment,diabetics on insulin

Exclusion criteria

Healthy volunteers,,hypertensive patients with normal blood glucose

Treatment and study plan

serum magnesium

Diagnostic Test

assessment of serum magnesium in all patients

Primary outcomes

Decrease in serum magnesium

Time frame: One month

statistical significant change in serum magnesium in diabetics with microalbuminuria

Sponsors and collaborators

Lead sponsor

Fayoum University

Other

Registry information

Official study title

Hypomagnesemia as a Marker of Diabeteiv Nephropathy

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Oct 1, 2018
Registry last updated: Sep 10, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed